Sjögren’s Syndrome News

Results from a systematic review of studies suggest there is inconclusive evidence about any association between silicone gel breast implants and long-term health outcomes.

SAN FRANCISCO — Leonard H. Calabrese, DO, of the Cleveland Clinic and Chief Medical Editor of Healio Rheumatology, reviews the importance of key studies on viruses, which were presented here at the American College of Rheumatology Annual Meeting.

The American College of Rheumatology Annual Meeting in San Francisco begins on Nov. 7, and Healio Rheumatology will cover the event and its many topics — ranging from rheumatoid arthritis to spondyloarthropathies, osteoarthritis, systemic lupus erythematosus, scleroderma, vasculitis, fibromyalgia, juvenile arthritis and much more— throughout the week.

Welcome to the Premier Issue of Healio Rheumatology, a print publication based on the most important news as measured by the online preferences of your colleagues. In this issue, you will find the most-read content from readers of Healio.com/Rheumatology, our online news site for rheumatology. We call this unique approach to issue content selection “Peer-Tested Content” and we believe the approach will provide you the best and most valuable content in your area of expertise.

Recently published data show patients with primary Sjögren’s syndrome who responded to treatment with Benlysta had lower levels of natural killer cells in both blood and saliva.

SLACK Incorporated, publisher of Healio.com, is set to expand its series of web-first news magazines delivering unique peer-tested content. Healio Rheumatology will compile the most-read content from Healio.com based on website metrics, and distribute it in a print news magazine reaching 6,100 U.S. physicians, including the universe of U.S. rheumatologists.

The Subcommittee on Primary Health and Retirement Security met on Thursday, September 17 for a hearing on the implementation of biosimilar agents with Janet Woodcock, MD, director of the Center for Drug Evaluation and Research at the FDA, and among other questions about interchangeability and safety, some senators questioned the lack of action in the issuance of guidance documents.

The presence of elevated autoantibodies against carbamylated proteins may be associated with disease activity in patients with primary Sjögren’s syndrome, according to a recently published study.

Hepatitis C virus immunoglobulin-G antibodies were detected in 8% to 13% of patients with Sjögren’s syndrome, depending on the classification criteria used, and in 45% of patients who met certain criteria, and rates were highest in patients with certain immunological profiles, according to researchers in Barcelona, Spain.